Am J Transplant, Volume 22, Suppl 3 Archives - Page 57 of 190 - ATC Abstracts

2022 American Transplant Congress
Regulatory T Cell PopulationsMay be Associated with Transplant Outcomes
H. Shin, S. Heo, Y. Kim, N. Lee, Y. Kim, Y. Jung, H. Rim
Internal Medicine, Kosin University College of Medicine,Transplantation Research Institute,Gospel Hospital, Busan, Korea, Republic of
*Purpose: The development of immunosuppressants has enabled remarkable progress in kidney transplantation (KT). However, current immunosuppressants cannot achieve induction of immune tolerance and their nonspecific…
2022 American Transplant Congress
Lung Transplantation For Covid-19: An International Registry
M. G. Ison¹, R. Giris², O. Dias³, R. Vos⁴, J. Magnusson⁵, T. Zangeneh⁶, E. D. Lease⁷, S. Aslam⁸, M. Weder⁹
¹Northwestern University Comprehensive Transplant Center, Chicago, IL, ²Spectrum Health, Grand Rapids, MI, ³Einstein Hospital, Buenos Aires, Argentina, ⁴UZ Leuven, Leuven, Belgium, ⁵Sahlgrenska Transplant Centre, Stockholm, Sweden, ⁶University of Arizona, Tucscon, AZ, ⁷University of Washington, Seattle, WA, ⁸University of California San Diego, San Diego, CA, ⁹University of Virginia, Charlottesville, VA
*Purpose: SARS-CoV-2 can result in a range of infections from asymptomatic disease to progressive COVID-19 and death. In some patients with COVID-19 Lung Disease (C19LD),…
2022 American Transplant Congress
Prospective Study of Preimplantation Biopsy in Deceased Donor Kidney Transplantation (DDKT)
H. Me, M. Smith, C. Jadlowiec, K. Harris, R. Butterfield, H. Khamash, B. G. AbuJawdeh, K. Reddy, R. Heilman
Mayo Clinic, Phoenix, AZ
*Purpose: Our aim was to study the impact of preimplantation biopsy (Bx) findings in selecting kidneys from more marginal donors.*Methods: This is a 2-year prospective…
2022 American Transplant Congress
De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation
G. Petrossian¹, J. Ortiz², K. Addonizio¹, A. Hsiao¹, L. Teixeira¹, N. Koizumi³, R. James³, S. Patel⁴, D. Conti², R. Plews²
¹Albany Medical Center, Albany, NY, ²Division of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, NY, ³George Mason University, Fairfax, VA, ⁴UMC Las Vegas, Las Vegas, NV
*Purpose: To compare the rate of CMV viremia and invasive disease in kidney transplantation patients with a de-novo belatacept (bela) regimen vs. a no-bela maintenance…
2022 American Transplant Congress
Outcomes in Obese Patients with Diabetes Mellitus Type 2 That Received Simultaneous Pancreas and Kidney Transplant
M. Merzkani¹, H. Murad², M. Wang³, V. Hu⁴, M. Ji⁵, Y. Al-Hosni⁴, O. Alzahabi³, M. Zayed³, K. Lentine⁶, J. Wellen⁷, S. Chang⁸, T. Alhamad⁹
¹Washington University, Saint Louis, MO, ²Washington University in St Louis, Chesterfield, MO, ³Washington U, St Louis, MO, ⁴Wash U, St Louis, MO, ⁵Washington University in St. Louis School of Medicine, Saint Louis, MO, ⁶SLU, St Louis, MO, ⁷Washington University School of Medicine, Saint Louis, MO, ⁸Surgery, Washington University School of Medicine, Saint Louis, MO, ⁹Washington University School of Medicine at St. Louis, Saint Louis, MO
*Purpose: Simultaneous pancreas and kidney transplant (SPKT) has excellent outcomes in patients with end stage renal disease secondary to diabetes mellitus type 2 (DMT2). The…
2022 American Transplant Congress
A Cost Effectiveness Analysis of Adherence Promotion Strategies to Improve Rejection Rates in Adolescent Kidney Transplant Patients
C. Varnell¹, K. Rich¹, A. Modi¹, D. Hooper¹, M. Eckman²
¹Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²University of Cincinnati School of Medicine, Cincinnati, OH
*Purpose: In adolescents with a kidney transplant, non-adherence increases the risk of graft loss. Adherence promotion interventions improve adherence and rejection rates, but perceived cost…
2022 American Transplant Congress
Role of Innate Immunity in Regulating Host Responses to Ischemia and Reperfusion and Allograft Rejection Injury in Vascularized Composite Allotransplantation
S. Han¹, X. Lai², J. Wang¹, L. VanOsdol³, C. Chen¹, J. Mathew¹, J. R. Leventhal⁴, Z. Zhang⁵
¹Northwestern University, Chicago, IL, ²Comprehensive Transplant Center, Microsurgery Core, Northwestern University, Chicago, IL, ³Comprehensive Transplant Center, Northwestern University, Chicago, IL, ⁴Surgery, Northwestern Medicine, Chicago, IL, ⁵Northwestern University Transplant Surgery, Chicago, IL
*Purpose: Vascularized composite tissue allotransplantation (VCA) 's wide application has been impeded by deleterious side-effect of current immunosuppressive regimens. This study is aimed to determine…
2022 American Transplant Congress
Novel Drug Target Identified for Reversal of Renal Tubular Injury
S. Sur, M. Kerwin, S. Pineda, M. Sarwal
UCSF, San Francisco, CA
*Purpose: Understanding the unique susceptibility of the human kidney tubule to oxidative cell stress and to identify compounds to support reversal of renal tubular damage.*Methods:…
2022 American Transplant Congress
Donor Factors Do Not Discriminate Living Donor Kidney Transplant Outcomes and Should Not Be Used to Promote the Use of Compatible Pairs in Kidney Paired Donation Programs
G. Irish¹, D. Chang², S. Chadban¹, N. Boudville¹, S. Campbell¹, J. Kanellis¹, L. McMichael², E. Sharples³, M. Kadatz², J. Gill², P. Clayton¹
¹ANZDATA, Adelaide, Australia, ²Providence Health Research Institute, Transplant Research, Vancouver, BC, Canada, ³Oxford University Trust Hospital, Oxford, United Kingdom
*Purpose: Enrolment of ABO blood group and HLA incompatible pairs in kidney paired donation programs improves matching potential. The benefit for compatible pairs, however, is…
2022 American Transplant Congress
Does Black Race Modify the Risk of Transplant Failure Associated with HLA Mismatch in First Adult Kidney Allografts from Deceased Donors?
K. Atiemo
Tulane University, New Orleans, LA
*Purpose: Current US- based data suggests Black patients awaiting kidney re-transplantation are more likely to be highly sensitized compared to other races. Degree of HLA…